HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045) [Phase 1]
A Phase 1 trial evaluating how doravirine (MK-1439) affects the pharmacokinetics of methadone in individuals maintained on methadone for HIV…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: HCV-HIV Co-infected Patient Cohort in Thailand [Phase 4]
Phase 4 trial completed for HCV-HIV co-infected patients in Thailand; results posted in 2019.
-
FDA approval · 2019-06-03FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original-application generic product of efavirenz, emtricitabine, and tenofovir disoproxil fumarate for HI…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: HealthCall-S: A Pilot Study Targeting Concurrent Non-injection Drug Use and Alcohol in HIV Primary Care Clinics [NA]
Pilot study update for HealthCall-S targeting concurrent non-injection drug use and alcohol in HIV primary care; completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics [Phase 4]
Phase 4 trial investigating protease inhibitors and combined oral contraceptive pharmacokinetics/pharmacodynamics was terminated; results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-30FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for SYMTUZA (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) submitted by Janssen Products…
-
FDA approval · 2019-05-28FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study) [Phase 3]
A phase 3 prospective study (LIVING) evaluating lopinavir-based ART for HIV-infected children globally has completed.
-
FDA approval · 2019-05-14FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for EDURANT (rilpivirine hydrochloride) from Janssen, updating the product's approval.
-
FDA approval · 2019-05-10FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company, resulting in label/indication changes thro…
-
FDA approval · 2019-05-10FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Combivir (lamivudine and zidovudine) by ViiV Healthcare Company.
-
FDA approval · 2019-05-03FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Triumeq (abacavir sulfate, dolutegravir sodium, lamivudine) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2019-05-02Clinical Trial Update: Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection [NA]
Clinical trial evaluating nurse case management to improve Hepatitis C care in individuals co-infected with HIV has completed with results p…
-
FDA approval · 2019-05-01FDA Approved: LAMIVUDINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original application for lamivudine (generic). Lamivudine is used in combination therapy for…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men [Phase 2]
Phase 2 clinical trial assessing tolerability, safety, and efficacy of Argon Plasma Coagulation for anal intraepithelial neoplasia in HIV-po…
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) [Phase 3]
A Phase 3 open-label trial evaluating two ABC/3TC-based regimens in late presenters with HIV infection who are treatment-naïve and have CD4 …
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing [NA]
A completed clinical trial evaluating a brief electronic intervention to reduce heavy drinking and sex risk among men who have sex with men …
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating intensification with Interferon Alpha 2b in HIV-positive individuals on antiretroviral therapy; completed with re…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) [Phase 3]
Phase 3 Gemini 2 trial compared dolutegravir with lamivudine against dolutegravir with tenofovir/emtricitabine in treatment-naïve HIV patien…
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing [NA]
A completed clinical trial evaluating a real-time, remote monitoring system for home-based HIV testing.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) [Phase 3]
A Phase 3 trial comparing dolutegravir plus lamivudine versus dolutegravir plus tenofovir/emtricitabine in treatment-naïve HIV patients has …
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). [Phase 1, Phase 2]
Early-phase trial assessing safety, tolerability, and immunogenicity of THV01 in HIV-1 clade B–infected patients on HAART; completed.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Dipyridamole for Immune Activation in HIV [Phase 1, Phase 2]
A clinical trial update for dipyridamole investigating immune activation in HIV, completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Phase 3]
Phase 3 trial comparing daily versus intermittent regimen of ATT (anti-tuberculosis therapy) in patients with HIV and pulmonary tuberculosis…
-
FDA approval · 2019-04-08FDA Approved: DOVATO — Original Application (ViiV Healthcare Company)
The FDA approved Dovato, a fixed-dose combination of dolutegravir and lamivudine, under an original NDA for the treatment of HIV-1 infection…